NO20080059L - Indol-3-karbonyl-spiro-piperidinderivater som V1A-reseptorantagonister - Google Patents

Indol-3-karbonyl-spiro-piperidinderivater som V1A-reseptorantagonister

Info

Publication number
NO20080059L
NO20080059L NO20080059A NO20080059A NO20080059L NO 20080059 L NO20080059 L NO 20080059L NO 20080059 A NO20080059 A NO 20080059A NO 20080059 A NO20080059 A NO 20080059A NO 20080059 L NO20080059 L NO 20080059L
Authority
NO
Norway
Prior art keywords
spiro
carbonyl
receptor antagonists
piperidine derivatives
indole
Prior art date
Application number
NO20080059A
Other languages
English (en)
Norwegian (no)
Inventor
Patrick Schnider
Hasane Ratni
Caterina Bissantz
Christophe Grundschober
Mark Rogers-Evans
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20080059L publication Critical patent/NO20080059L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20080059A 2005-07-14 2008-01-04 Indol-3-karbonyl-spiro-piperidinderivater som V1A-reseptorantagonister NO20080059L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05106443 2005-07-14
EP05109364 2005-10-07
PCT/EP2006/063846 WO2007006688A1 (fr) 2005-07-14 2006-07-04 Derives d'indol-3-carbonyl-spiro-piperidine en tant qu'antagonistes du recepteur v1a

Publications (1)

Publication Number Publication Date
NO20080059L true NO20080059L (no) 2008-04-02

Family

ID=37001896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080059A NO20080059L (no) 2005-07-14 2008-01-04 Indol-3-karbonyl-spiro-piperidinderivater som V1A-reseptorantagonister

Country Status (26)

Country Link
US (2) US7332501B2 (fr)
EP (1) EP1904477B1 (fr)
JP (1) JP4927079B2 (fr)
KR (1) KR100974967B1 (fr)
CN (1) CN101253164B (fr)
AR (1) AR054830A1 (fr)
AT (1) ATE421511T1 (fr)
AU (1) AU2006268724B2 (fr)
BR (1) BRPI0612988A2 (fr)
CA (1) CA2615726C (fr)
CY (1) CY1108996T1 (fr)
DE (1) DE602006004997D1 (fr)
DK (1) DK1904477T3 (fr)
ES (1) ES2317558T3 (fr)
HK (1) HK1123554A1 (fr)
IL (1) IL188478A (fr)
MX (1) MX2008000585A (fr)
MY (1) MY144684A (fr)
NO (1) NO20080059L (fr)
PL (1) PL1904477T3 (fr)
PT (1) PT1904477E (fr)
RU (1) RU2414466C2 (fr)
SI (1) SI1904477T1 (fr)
TW (1) TWI312780B (fr)
WO (1) WO2007006688A1 (fr)
ZA (1) ZA200800320B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006004997D1 (de) * 2005-07-14 2009-03-12 Hoffmann La Roche Indol-3-carbonyl-spiro-piperidinderivate als antagonisten des v1a-rezeptors
WO2007039438A1 (fr) * 2005-09-28 2007-04-12 F. Hoffmann-La Roche Ag Composés indol-3-ylcarbonylazaspiro en tant qu'antagonistes du récepteur de la vasopressine
US7351706B2 (en) * 2006-01-05 2008-04-01 Hoffmann-La Roche Inc. Indol-3-yl-carbonyl-spiro-piperidine derivatives
RU2009119394A (ru) 2006-12-07 2011-01-20 Ф. Хоффманн-Ля Рош Аг (Ch) Производные спиро-пиперидина в качестве антагонистов рецептора v1a
US7799923B2 (en) 2006-12-08 2010-09-21 Hoffmann-La Roche Inc. Indoles
CA2673307A1 (fr) * 2006-12-22 2008-07-03 F. Hoffman-La Roche Ag Derives de spiropiperidine
EP2104677B1 (fr) * 2007-01-12 2011-12-07 F. Hoffmann-La Roche AG Dérivés de spiropipéridine glycinamide
TW200940547A (en) * 2007-12-13 2009-10-01 Speedel Experimenta Ag Organic compounds
US8785634B2 (en) * 2010-04-26 2014-07-22 Merck Sharp & Dohme Corp Spiropiperidine prolylcarboxypeptidase inhibitors
AU2012226475C1 (en) 2011-03-10 2015-08-06 Zoetis Services Llc Spirocyclic isoxazoline derivatives as antiparasitic agents
RU2475489C1 (ru) * 2011-10-07 2013-02-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Чувашский государственный университет имени И.Н. Ульянова" Способ получения 8-амино-1-имино-6-морфолин-4-ил-2-окса-7-азаспиро[4,4]нона-3,6,8-триен-9-карбонитрилов
RS55166B1 (sr) 2012-03-16 2017-01-31 Vitae Pharmaceuticals Inc Modulatori x receptora iz jetre
LT2825542T (lt) 2012-03-16 2016-12-27 Vitae Pharmaceuticals, Inc. Kepenų x receptoriaus moduliatoriai
JO3109B1 (ar) * 2012-05-10 2017-09-20 Ferring Bv منبهات لمستقبلات v1a
KR101698124B1 (ko) * 2015-05-29 2017-01-19 한국외국어대학교 연구산학협력단 3-(메틸아미노)-3-((r)-피롤리딘-3-일)프로판니트릴 또는 이의 염의 제조방법
CN108884096B (zh) * 2016-02-08 2022-03-22 豪夫迈·罗氏有限公司 作为ddr1抑制剂的螺二氢吲哚酮
US20180002344A1 (en) 2016-06-16 2018-01-04 Genentech, Inc. Heteroaryl estrogen receptor modulators and uses thereof
CN110234631B (zh) 2016-09-21 2023-02-28 维克特斯生物系统有限公司 用于治疗高血压和/或纤维化的组合物
HU231206B1 (hu) 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepinek
TW201938171A (zh) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 作為血管升壓素V1a受體拮抗劑之三環化合物
CN113563255B (zh) * 2020-04-29 2023-08-18 成都倍特药业股份有限公司 瑞芬沙星中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686624A (en) * 1992-01-30 1997-11-11 Sanofi 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
EP1410437A2 (fr) * 2001-01-22 2004-04-21 Morgan Chemical Products, Inc. Systeme de refroidissement pour microprocesseurs ameliore avec diffuseur de chaleur a diamant cvd
DE602006004997D1 (de) * 2005-07-14 2009-03-12 Hoffmann La Roche Indol-3-carbonyl-spiro-piperidinderivate als antagonisten des v1a-rezeptors

Also Published As

Publication number Publication date
RU2008100082A (ru) 2009-08-20
CN101253164B (zh) 2012-05-16
PT1904477E (pt) 2009-03-12
KR20080024231A (ko) 2008-03-17
DE602006004997D1 (de) 2009-03-12
CY1108996T1 (el) 2014-07-02
EP1904477A1 (fr) 2008-04-02
ES2317558T3 (es) 2009-04-16
MX2008000585A (es) 2008-03-14
EP1904477B1 (fr) 2009-01-21
CA2615726C (fr) 2014-05-27
BRPI0612988A2 (pt) 2010-12-14
TW200726469A (en) 2007-07-16
SI1904477T1 (sl) 2009-06-30
IL188478A0 (en) 2008-04-13
US7332501B2 (en) 2008-02-19
KR100974967B1 (ko) 2010-08-09
CN101253164A (zh) 2008-08-27
WO2007006688A1 (fr) 2007-01-18
US20080146557A1 (en) 2008-06-19
US7629353B2 (en) 2009-12-08
RU2414466C2 (ru) 2011-03-20
ZA200800320B (en) 2009-02-25
US20070027173A1 (en) 2007-02-01
DK1904477T3 (da) 2009-03-16
AU2006268724A1 (en) 2007-01-18
AR054830A1 (es) 2007-07-18
CA2615726A1 (fr) 2007-01-18
HK1123554A1 (en) 2009-06-19
AU2006268724B2 (en) 2011-06-02
TWI312780B (en) 2009-08-01
ATE421511T1 (de) 2009-02-15
PL1904477T3 (pl) 2009-07-31
MY144684A (en) 2011-10-31
JP4927079B2 (ja) 2012-05-09
IL188478A (en) 2012-01-31
JP2009501185A (ja) 2009-01-15

Similar Documents

Publication Publication Date Title
NO20080059L (no) Indol-3-karbonyl-spiro-piperidinderivater som V1A-reseptorantagonister
NO20082733L (no) Indol-3-yl-karbonyl-spiro-piperidinderivater
WO2007014851A3 (fr) Derives de indol-3-yl-carbonyl-piperidine et piperazine
NO20080291L (no) Indol-3-yl-karbonyl-piperidin-benzomidazolderivater som Via reseptorantagonister
NO20071660L (no) Nye pyridinonderivater og deres anvendelse som positive allosteriske modulatorer av MGLUR2-reseptorer
NO20064579L (no) Bifenylforbindelser anvendelige som muskariniske receptorantagonister
WO2006021213A3 (fr) Antagonistes de récepteur v1a la vasopressine v1a
WO2010036613A8 (fr) Nouveaux dérivés de benzimidazole cycliques utiles en tant qu'agents anti-diabétiques
NO20083500L (no) 1,4-disubstituerte 3-cyano-pyridonderivater og deres anvendelse som positiv-allosteriske modulatorer av mGluR2 receptorer
NO20092762L (no) 2-aza-bicyklo[3.1.0]heksanderivater
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
EP2548568A3 (fr) Ligands des récépteurs de la mélanocortine
NO20073019L (no) Pyrasolonforbindelser som metabotrope glutamatreseptor-antagonister for behandlingen av nevrotiske og psykiatriske lidelser
WO2007115077A3 (fr) Composés de benzimidazole bicyclique et leur utilisation comme potentialisateurs du récepteur métabotropique du glutamate
WO2008070462A3 (fr) N-oxydes d'analogues 4,5-époxy-morphinanium
NO20051626L (no) Azw-bicykloalkyletere og deres anvendelse som alfa-7-nAChR agonister
CY1108880T1 (el) Παραγωγα καρβοξαμιδιου ως ανταγωνιστες μουσκαρινικου υποδοχεα
WO2007127297A3 (fr) Formes cristallines d'un composé de diméthylphényle
NO20076060L (no) Piperidin-4-yl-amidderivater og deres anvendelse som SST-reseptor subtype 5-antagonister
WO2009024989A3 (fr) Nouvelle forme hydratée de base libre d'erlotinib et procédé de préparation de la forme polymorphe a de chlorhydrate d'erlotinib sensiblement exempte de la forme polymorphe b
WO2008099072A3 (fr) Nouveaux derives de 2, 4-dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
NO20080457L (no) Kjemiske forbindelser
NO20083583L (no) Heterosykliske antivirale forbindelser
WO2009034432A3 (fr) Nouveaux composés actifs utilisés comme antagonistes des récepteurs muscariniques

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application